

Galleri® MULTI-CANCER EARLY DETECTION TEST
Go Further with Cancer Screening
Treating cancer starts with knowing you have it. Introducing the Galleri® test*—a groundbreaking innovation in early cancer detection. The test can find a signal shared across more than 50 types of cancer with a simple blood draw.
The Galleri test is recommended for use in adults who are at risk for cancer, such as those aged 50 or older. It is intended to be used in addition to, and not replace, other cancer screening tests.


What is the Galleri® Test?
Galleri®redefines what’s possible. Only 5 cancers have recommended screening tests. Using Galleri® in addition to these tests can increase the chance of finding cancer early, to allow for earlier treatment.
With a single blood test, Galleri® screens for a signal shared by multiple cancers that would otherwise go unnoticed. If a cancer signal is detected, Galleri predicts the tissue type or organ associated with the cancer signal with 88% accuracy* to help guide follow-up diagnostic testing which may include lab work or imaging to confirm cancer.
*In the PATHFINDER study, Cancer Signal Origin (CSO) prediction accuracy was 88% for participants with a cancer diagnosis among study participants with a "Cancer Signal Detected" test result.
Benefits of Galleri® Multi-Cancer Early Detection Test
-
Screens Beyond Routine Tests
Detects 50+ cancers not typically included in standard screenings.
-
Extremely Low False Positives
Proven 0.5% false positive rate—high confidence, low worry.
-
Detects Active Cancer Signals
Identifies presence of cancer, not just genetic risk factors.
-
Pinpoints Cancer Location
Locates where in the body the cancer signal is coming from.
interested in learning more?

